|
HY-100302-1mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100302-10mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100302-100mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100302-25mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100302-5mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100302-50mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-103528-5mg
|
MedChemexpress LLC
|
SCS [CAS 3232-36-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-114353-1mg
|
MedChemexpress LLC
|
BDP FL azide [CAS 1379771-95-5]
|
|
|
|
|
HY-114353-5mg
|
MedChemexpress LLC
|
BDP FL azide [CAS 1379771-95-5]
|
|
|
|
|
HY-B1306S-1mg
|
MedChemexpress LLC
|
4-Aminohippuric acid-d4 [CAS 1219805-41-0]
|
|
|
|
|
HY-D0006-1g
|
MedChemexpress LLC
|
Bathophenanthroline [CAS 1662-01-7]
|
|
|
|
|
HY-D0006-500mg
|
MedChemexpress LLC
|
Bathophenanthroline [CAS 1662-01-7]
|
|
|
|
|
HY-N0157-100mg
|
MedChemexpress LLC
|
Orotic acid [CAS 65-86-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-N0157-500mg
|
MedChemexpress LLC
|
Orotic acid [CAS 65-86-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-P2573-10mg
|
MedChemexpress LLC
|
Suc-AAPF-pNA [CAS 70967-97-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-P2573-25mg
|
MedChemexpress LLC
|
Suc-AAPF-pNA [CAS 70967-97-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-P2573-5mg
|
MedChemexpress LLC
|
Suc-AAPF-pNA [CAS 70967-97-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-W034953-100mg
|
MedChemexpress LLC
|
Bathocuproine disulfonate (disodium) [CAS 52698-84-7]
|
|
|
|
|
HY-W034953-250mg
|
MedChemexpress LLC
|
Bathocuproine disulfonate (disodium) [CAS 52698-84-7]
|
|
|
|
|
HY-W040143-1g
|
MedChemexpress LLC
|
2',7'-Dichlorofluorescein [CAS 76-54-0]
|
|
Cancer-programmed cell death
|
|
|
HY-W040143-5g
|
MedChemexpress LLC
|
2',7'-Dichlorofluorescein [CAS 76-54-0]
|
|
Cancer-programmed cell death
|
|
|
HY-N0157-1mL
|
MedChemexpress LLC
|
Orotic acid [CAS 65-86-1] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-P4426A-1mg
|
MedChemexpress LLC
|
Lys-Pro-AMC (diTFA)
|
|
|
|
|
HY-P4426A-10mg
|
MedChemexpress LLC
|
Lys-Pro-AMC (diTFA)
|
|
|
|
|
HY-P4426A-25mg
|
MedChemexpress LLC
|
Lys-Pro-AMC (diTFA)
|
|
|
|
